Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Capital Expenditures of -$77.6 million for Q1 2026, down 4.77% year-over-year from -$81.5 million in Q1 2025, and up 25.38% quarter-over-quarter from -$103.9 million in Q4 2025.
Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Capital Expenditures for 7 consecutive years, with -$77.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 4.77% year-over-year to -$77.6 million; the TTM figure through Mar 2026 stood at -$301.0 million (down 3.12% YoY), while the FY2025 annual figure was -$307.1 million, up 5.04% from the prior year.
- Capital Expenditures climbed to -$77.6 million in Q1 2026 per STVN's latest filing, from -$103.9 million in the prior quarter.
- Across five years, Capital Expenditures topped out at -$40.7 million in Q3 2022 and bottomed at -$142.9 million in Q3 2023.
- Historically, Capital Expenditures has averaged -$83.5 million across 5 years, with a median of -$77.6 million in 2026.
- Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 250.89% — and 2024, when it surged 65.84%.
- Stevanato Group S.p.A's Capital Expenditures stood at -$69.3 million in 2022, then dropped by 27.36% to -$88.2 million in 2023, then retreated by 7.67% to -$95.0 million in 2024, then declined by 9.42% to -$103.9 million in 2025, then grew by 25.38% to -$77.6 million in 2026.
- Business Quant data shows STVN's Capital Expenditures at -$77.6 million in Q1 2026, -$103.9 million in Q4 2025, and -$54.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | -66.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -66.95 Mn |
| Jun 30, 2026 | -66.95 Mn |
| Mar 31, 2026 | -77.57 Mn |
| Mar 31, 2026 | -77.57 Mn |
| Dec 31, 2025 | -103.95 Mn |
| Dec 31, 2025 | -103.95 Mn |
| Sep 30, 2025 | -54.26 Mn |
| Sep 30, 2025 | -54.26 Mn |
| Jun 30, 2025 | -65.21 Mn |
| Jun 30, 2025 | -65.21 Mn |
| Mar 31, 2025 | -74.04 Mn |
| Mar 31, 2025 | -74.04 Mn |
| Dec 31, 2024 | -95.00 Mn |
| Dec 31, 2024 | -95.00 Mn |
| Sep 30, 2024 | -48.83 Mn |
| Sep 30, 2024 | -48.83 Mn |
| Jun 30, 2024 | -74.00 Mn |
| Jun 30, 2024 | -74.00 Mn |
| Mar 31, 2024 | -109.22 Mn |
| Mar 31, 2024 | -109.22 Mn |